mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases.
Johnson SC, Martinez F, Bitto A, Gonzalez B, Tazaerslan C, Cohen C, Delaval L, Timsit J, Knebelmann B, Terzi F, Mahal T, Zhu Y, Morgan PG, Sedensky MM, Kaeberlein M, Legendre C, Suh Y, Canaud G.
Johnson SC, et al. Among authors: sedensky mm.
Kidney Int. 2019 Feb;95(2):455-466. doi: 10.1016/j.kint.2018.08.038. Epub 2018 Nov 22.
Kidney Int. 2019.
PMID: 30471880
Free PMC article.